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Abstract
All pathogenesis and death associated with Plasmodium falciparum malaria is due to parasite-infected erythrocytes. Invasion
of erythrocytes by P. falciparum merozoites requires specific interactions between host receptors and parasite ligands that
are localized in apical organelles called micronemes. Here, we identify cAMP as a key regulator that triggers the timely
secretion of microneme proteins enabling receptor-engagement and invasion. We demonstrate that exposure of
merozoites to a low K+ environment, typical of blood plasma, activates a bicarbonate-sensitive cytoplasmic adenylyl cyclase
to raise cytosolic cAMP levels and activate protein kinase A, which regulates microneme secretion. We also show that cAMP
regulates merozoite cytosolic Ca2+ levels via induction of an Epac pathway and demonstrate that increases in both cAMP
and Ca2+ are essential to trigger microneme secretion. Our identification of the different elements in cAMP-dependent
signaling pathways that regulate microneme secretion during invasion provides novel targets to inhibit blood stage
parasite growth and prevent malaria.
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Introduction
All the clinical symptoms of Plasmodium falciparum malaria are
attributed to the blood stage of the parasite life cycle. The intra-
erythrocytic stage of the life cycle is initiated when liberated P.
falciparum merozoites invade and multiply within host red blood
cells. Following the development of mature schizonts, next
generation merozoites egress from infected erythrocytes and
invade uninfected erythrocytes to start a new cycle of infection.
Invasion of erythrocytes by P. falciparum merozoites is a complex
multi-step process that is mediated by specific molecular interac-
tions between red cell surface receptors and parasite protein
ligands [1,2]. A number of parasite ligands that mediate receptor
binding during invasion reside in apical membrane-bound
organelles known as micronemes and rhoptries [1,2]. Timely
secretion of these parasite ligands to the merozoite surface is
critical for successful invasion [3,4].
Microneme and rhoptry proteins are secreted from free P.
falciparum merozoites in a two-step process [5]. First, exposure of
extracellular merozoites to a low [K+] environment typical of
blood plasma leads to a rise in cytosolic Ca2+ via a phospholipase
C (PLC)-dependent pathway, which triggers translocation of
microneme proteins such as 175 kD erythrocyte binding antigen
(EBA175) and apical merozoite antigen-1 (PfAMA1) to the
merozoite surface [5]. Subsequently, binding of EBA175 and its
homologs to their erythrocyte receptors triggers secretion of
rhoptry proteins such as PfRH2b, Clag3.1 and PfTRAMP [5,6].
The pathways by which exposure of P. falciparum merozoites
to a low K+ environment triggers a rise in cytosolic Ca2+ and
microneme secretion are not understood. Here, we demonstrate
that another ubiquitous second messenger, namely, 3’-5’ cyclic
adenosine monophosphate (cAMP), plays a central role in
regulating cytosolic Ca2+ levels and microneme secretion during
merozoite invasion of red blood cells. We demonstrate that
exposure of merozoites to a low K+ environment as found in blood
plasma activates the bicarbonate-sensitive cytoplasmic adenylyl
cyclase b (PfACb) leading to a rise in cytosolic cAMP levels and
activation of protein kinase A (PKA), which regulates microneme
secretion. In mammalian cells, the cAMP responsive PKA, which
regulates diverse cellular processes in response to a rise in cytosolic
cAMP levels, is composed of two catalytic subunits and two
regulatory subunits [7]. Unlike mammalian cells, P. falciparum
has a single inhibitory regulatory subunit (PfPKAr) and a single
catalytic subunit (PfPKAc) [8–12]. As the PfPKAr subunit is not
predicted to dimerize, the holoenzyme is likely to be composed of
a one-to-one ratio of PfPKAr:PfPKAc [12]. The PfPKAr subunit
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is predicted to have 2 cyclic nucleotide binding domains. When
cAMP binds to one or both of these it provokes a conformational
change that engenders the dissociation of the PfPKAr:PfPKAc
complex and activation of the released PfPKAc subunit that
phosphorylates its specific substrates [8–12]. Like Plasmodium,
Toxoplasma also encodes cAMP-dependent PKA and its inhibition
leads to a block in tachyzoite growth [13]. Increase in cytosolic
cAMP levels that would activate Toxoplasma PKA also mediates
the tachyzoite to bradyzoite developmental switch [14–16]. In
addition to activating PKA, we demonstrate that cAMP activates
the Epac pathway [17] in P. falciparum merozoites, which triggers
a rise in cytosolic Ca2+ leading to microneme release. cAMP thus
plays a central role in regulating microneme secretion during red
blood cell invasion by P. falciparum merozoites.
Results
cAMP production by adenylyl cyclase b (PfACb) in P.
falciparum merozoites
cAMP is produced in eukaryotic cells either by a transmem-
brane adenylyl cyclase (tmAC), which has a putative K+ channel at
the N-terminus, or by a cytoplasmic soluble adenylyl cyclase (sAC).
Homologs of both the tmAC (PF3D7_1404600) and sAC
(PF3D7_0802600) (www.plasmodb.org) are encoded in P. falci-
parum genome [18,19]. However, the gene encoding the P.
berghei transmembrane AC (PbACa) has been knocked out with
no deleterious effect on growth of blood stage parasites although
sporozoites are impaired in hepatocyte infectivity [20]. Given that
PbACa does not appear to have an essential role in blood stage
growth we focused our attention on the soluble AC in P.
falciparum (PfACb).
Mouse antiserum raised against a synthetic peptide derived
from PfACb detects a protein of expected size (.250 kD) in
schizont and merozoite lysates by Western blotting (S1 Figure).
Detection of PfACb by immunofluorescence assay (IFA) demon-
strates that it co-localizes in late stage schizonts and merozoites
with the cytoplasmic protein PfNapL [21] (Fig. 1). PfACb is thus
expressed in P. falciparum merozoites and is localized in the
cytoplasm.
Exposure of P. falciparum merozoites to an ionic environment
with low K+ as found in blood plasma triggers a rise in cytosolic
Ca2+ and secretion of microneme proteins [5]. To determine if
exposure of free merozoites to a low K+ environment also leads to
a rise in cytosolic cAMP, we measured cAMP levels in purified
merozoites suspended in a buffer that mimics the intracellular
ionic environment (IC buffer – 140 mM KCl, 5 mM NaCl, 1 mM
MgCl2, 5.6 mM glucose, 25 mM HEPES, pH 7.2) and following
transfer to a buffer that mimics extracellular ionic environment
with low K+ levels (EC buffer – 5 mM KCl, 140 mM NaCl, 1 mM
MgCl2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2).
cAMP levels were also measured before and after merozoites were
transferred from IC to IC-Klow buffer (IC-Klow buffer – 5 mM
NaCl, 5 mM KCl, 135 mM choline-Cl, 1 mM EGTA, 5.6 mM
glucose, 25 mM HEPES, pH 7.2) to determine if change in
environmental K+ level alone can trigger changes in cAMP levels.
There is a distinct rise in cAMP when merozoites are transferred
from IC to EC buffer, or from IC to IC-Klow buffer (Fig. 1B).
Importantly, transfer of free merozoites to a low K+ buffer in the
presence of KH7, which inhibits mammalian sAC [19], blocks the
rise in cytosolic cAMP (Fig. 1C).
Regulation of microneme secretion by cAMP
We monitored the secretion of microneme protein PfAMA1
following the transfer of free P. falciparum merozoites from IC to
EC buffer with or without prior treatment with KH7. PfAMA1 is
proteolytically cleaved into 48 kD and 44 kD fragments that are
released into the supernatant following translocation to the
merozoite surface [22]. PfAMA1 was detected in merozoite
supernatants following transfer from IC to EC buffer by Western
blotting using anti-PfAMA1 sera (Fig. 1D). Transfer of extracel-
lular merozoites from IC to EC buffer in the presence of KH7
blocks the secretion of PfAMA1 (Fig. 1D). Treatment of merozo-
ites with KH7 in the presence of 3-isobutyl-1-methylxanthine
(IBMX), which inhibits 3’,5’-cAMP phosphodiesterase (PDE) and
maintains high cAMP levels in cells [23], reverses the block in
microneme secretion (Fig. 1D). Secretion of another microneme
protein, EBA175, is also inhibited if merozoites are treated with
KH7 prior to transfer from IC to EC buffer (S2 Figure).
cAMP production in P. falciparum merozoites upon
exposure to a low K+ environment
Production of cAMP by soluble adenylyl cyclases is regulated by
HCO3
2 ions in diverse organisms [24–26]. Incubation of P.
falciparum merozoite lysates with ATP and different concentra-
tions of HCO3
2 ions showed that increasing amounts of cAMP
are produced in presence of increasing concentrations of HCO3
2
ions suggesting the presence of a HCO3
2 sensitive adenylyl cyclase
activity (Fig. 2A). Moreover, cAMP production is inhibited by
KH7 (Fig. 2A). These observations confirm the presence of a
HCO3
2-sensitive ACb in free P. falciparum merozoites.
Cytosolic pH (pHi) is controlled in eukaryotic cells by carbonic
anhydrase (CA), which catalyzes the reversible hydration of CO2
to produce H+ and HCO3
2 (CO2+H2O«HCO32+H+) [27].
Acetazolamide (ACTZ), a specific inhibitor of CA, can disrupt
intracellular pH homeostasis [28,29]. We tested whether the
transfer of free merozoites from IC to EC buffer in presence of
ACTZ affects pHi. P. falciparum merozoites collected in IC buffer
were loaded with the membrane permeable pH-sensitive fluores-
cent dye BCECF-AM [30] and transferred to EC buffer in the
presence or absence of ACTZ. pHi does not change when free
merozoites are transferred from IC to EC buffer. In contrast, there
Author Summary
The blood stage of malaria parasites is responsible for all
the morbidity and mortality associated with malaria.
During the blood stage, malaria parasites invade and
multiply within host erythrocytes. The process of erythro-
cyte invasion requires specific interactions between host
receptors and parasite ligands. Many of the key parasite
proteins that bind host receptors are localized in apical
organelles called micronemes. Here, we demonstrate that
cAMP serves as a key regulator that controls the timely
secretion of microneme proteins during invasion. We show
that exposure of merozoites to a low K+ environment, as
found in blood plasma, leads to a rise in cytosolic cAMP
levels due to activation of the cytoplasmic, bicarbonate-
sensitive adenylyl cyclase b (PfACb). A rise in cAMP
activates protein kinase A (PKA), which regulates micro-
neme secretion. In addition, cAMP triggers a rise in
cytosolic Ca2+ levels through the Epac pathway. Increases
in both cAMP and Ca2+ levels are essential for triggering
microneme secretion. Identification of the different ele-
ments in the cAMP-dependent signaling pathways that
regulate microneme secretion during invasion provides
novel targets to block erythrocyte invasion, inhibit blood
stage parasite growth and prevent malaria.
cAMP-Mediated Regulation of Microneme Exocytosis
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Fig. 1. Production of cAMP in P. falciparummerozoites by adenylyl cyclase b (PfACb) and microneme exocytosis. A) Expression of PfACb
in P. falciparum blood stages. Immunofluorescence assays (IFA) were used to detect PfACb (green) in P. falciparum rings (i), trophozoites (ii), schizonts
(iii) and merozoites (iv) using mouse antisera against a peptide derived from PfACb. Nuclear DNA was stained with DAPI (blue). Rabbit antiserum
against P. falciparum cytoplasmic protein PfNAPL (red) was used for co-localization. Yellow indicates overlap of PfACb and PfNAPL. B) Exposure of P.
falciparum merozoites to low K+ triggers production of cAMP. P. falciparum merozoites were isolated in buffer mimicking intracellular ionic
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is a rapid rise in pHi when free merozoites are transferred from IC
to EC buffer in presence of ACTZ (Fig. 2B). These observations
indicate that PfCA activity is necessary for maintenance of pHi
when merozoites are transferred to a low K+ environment.
The observation that pHi rises when merozoites are transferred
to EC in presence of ACTZ is consistent with a model in which
PfCA maintains pHi by producing H
+ and HCO3
2. To test
whether the generation of HCO3
2 in free merozoites following
transfer from IC to EC buffer leads to activation of PfACb, we
measured levels of cAMP in merozoites with or without treatment
with ACTZ. Treatment of merozoites with ACTZ prior to transfer
from IC to EC buffer inhibits rise in cAMP (Fig. 2C) as well as
secretion of PfAMA1 (Fig. 2D). Treatment of P. falciparum
merozoites with ACTZ in presence of IBMX reverses the block in
microneme secretion (Fig. 2D). These results suggest that when
free merozoites are exposed to an extracellular-like low K+
environment, the production of HCO3
2 by PfCA to maintain pHi
leads to activation of PfACb and generation of cAMP, which
triggers microneme secretion. Exposure of merozoites in IC buffer
to increasing concentrations of HCO3
2 also leads to a dose-
dependent increase in microneme secretion (S3 Figure) confirming
that HCO3
2 plays a key role in regulating microneme secretion.
Potential role of cAMP-responsive protein kinase A (PKA)
in regulation of microneme secretion
PKA commonly plays a role as a cAMP-responsive effector in
signaling pathways [7]. To investigate the potential role of PfPKA
in microneme discharge, we measured phosphorylation of
kemptide, a specific substrate of PKA, by lysates of P. falciparum
merozoites in IC and EC buffers with and without addition of
KH7. There is a distinct increase in kemptide phosphorylation
with lysates made from merozoites in EC buffer compared to IC
buffer (Fig. 3A). Pre-treatment with KH7 inhibits this increase in
kemptide phosphorylation by merozoite lysates in EC buffer
suggesting that a cAMP-responsive kinase is activated when
merozoites are transferred to EC buffer (Fig. 3A).
We used a molecular genetic approach to explore the regulatory
role of PfPKA in microneme secretion. The P. falciparum
transgenic line PHL dhfr-PfPKAr over-expresses the regulatory
subunit (PfPKAr) (11, S4 Figure). Overexpression of PfPKAr
results in reduced PKA activity and a parasite growth defect,
which is restored by addition of the non-hydrolyzable cAMP
analog dibutryl-cAMP (DiB) [11]. In contrast to wild type P.
falciparum merozoites (Fig. 3A), lysates of P. falciparum PHL
dhfr-PfPKAr merozoites in EC buffer do not phosphorylate
kemptide at higher levels compared to lysates made in IC buffer
(Fig. 3B). Treatment of P. falciparum PHL dhfr-PfPKAr mero-
zoite lysates with DiB increases kemptide phosphorylation
(Fig. 3B). These observations indicate that kemptide phosphory-
lation is primarily due to PfPKA and PfPKA activity increases
when merozoites are transferred from IC to EC buffer.
Next, we followed secretion of PfAMA1 upon transfer of P.
falciparum PHL dhfr-PfPKAr merozoites from IC to EC buffer
with and without DiB treatment (Fig. 3C). PfAMA1 is not secreted
when P. falciparum PHL dhfr-PfPKAr merozoites are transferred
from IC to EC buffer (Fig. 3C). However, PfAMA-1 secretion is
restored when P. falciparum PHL dhfr-PfPKAr merozoites are
treated with DiB in EC buffer presumably due to the activation of
PfPKA (Fig. 3C). These observations suggest that PfPKA plays a
role in regulation of microneme secretion. Impairment of
microneme secretion due to PfPKAr overexpression may be one
of the reasons for poor growth of P. falciparum PHL dhfr-PfPKAr
parasites.
Crosstalk between cAMP and Ca2+ signaling in P.
falciparum merozoites and regulation of microneme
secretion
Changes in the levels of cytosolic Ca2+ and cAMP control a
variety of functions in diverse cell types [31]. We examined the
crosstalk between these two ubiquitous second messengers in
extracellular P. falciparum merozoites. We found that treatment
of merozoites with the Ca2+ chelator, BAPTA-AM, or PLC
inhibitor, U73122, does not affect the increase in cAMP levels
when merozoites are transferred from IC to EC buffer (Fig. 4A).
In contrast, treatment of merozoites with the ACb inhibitor KH7
inhibits the increase in cytosolic Ca2+ levels when merozoites are
transferred from IC to EC buffer (Fig. 4B) indicating that cAMP
plays a key role in regulating cytosolic Ca2+ levels in P. falciparum
merozoites.
Next, we found that Ca2+ levels increase in transgenic P.
falciparum PHL dhfr-PKAr merozoites following their transfer
from IC to EC buffer (Fig. 4B). Moreover, treatment of transgenic
merozoites with DiB in IC buffer, which activates PfPKA, does not
lead to further increase in cytosolic Ca2+ levels (Fig. 4C). These
observations indicate that PfPKA does not play a role in
generation of free cytosolic Ca2+ in P. falciparum merozoites
following transfer from IC to EC buffer.
Alternative cAMP-responsive effectors, Epac 1 and Epac 2,
have been shown to activate phospholipase C (PLC) in presence of
cAMP leading to rise in cytosolic Ca2+ in mammalian cells
[17,32,33]. P. falciparum codes for a single putative parasite
PfEpac (PF3D7_1417400). Treatment of merozoites in IC buffer
environment (IC buffer – 140 mM KCl, 5 mM NaCl, 1 mM MgCl2, 5.6 mM glucose, 25 mM HEPES, pH 7.2) and transferred to buffer mimicking
extracellular ionic environment (EC buffer – 5 mM KCl, 140 mM NaCl, 1 mM MgCl2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2) or IC-Klow
buffer (IC-Klow buffer – 5 mM NaCl, 5 mM KCl, 135 mM choline-Cl, 1 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2). Levels of cytosolic cAMP in
merozoite lysates were measured using a colorimetric cAMP Direct Immunoassay Kit (Calbiochem) as described in Materials & Methods. Total protein
content in each merozoite sample was determined using Pierce Protein Assay Kit (Pierce). Amount of cAMP per mg of protein was determined for
each merozoite sample and used to calculate fold increase compared to cAMP per mg of protein in control merozoites in IC buffer. Graphs represent
mean fold change (6 SD) in cAMP levels per mg of protein in merozoites under different conditions with respect to cAMP per mg of protein in
merozoites in IC buffer from three independent experiments. C) Mammalian soluble AC inhibitor KH7 blocks rise in cytosolic cAMP levels following
transfer of P. falciparum merozoites to low K+ buffer. P. falciparum merozoites were isolated in IC buffer and transferred to EC buffer with or without
treatment with KH7. Levels of cAMP were measured in merozoite lysates as described above. Graphs represent mean fold change (6 SD) in cAMP
levels per mg of protein in merozoites under different conditions with respect to cAMP per mg of protein in merozoites in IC buffer from three
independent experiments. Treatment with KH7 inhibits increase in cytosolic cAMP levels when merozoites are transferred from IC to EC buffer. D)
Inhibition of microneme secretion by KH7. P. falciparum merozoites were transferred from IC to EC buffer with or without treatment with KH7.
Secretion of PfAMA1 in merozoite supernatants (AMA(s)) was detected by Western blotting. Presence of cytoplasmic protein PfNapL was detected in
P. falciparum merozoite supernatants (NapL(s)) and lysates of merozoite pellets (NapL(p)) under different conditions by Western blotting to control
for merozoite lysis and number of merozoites used in the different conditions, respectively. Treatment of merozoites with KH7 inhibits secretion of
microneme protein PfAMA1 following transfer from IC to EC buffer. Treatment of merozoites with KH7+IBMX, KH7+DiB+Epac Agonist and KH7+DiB+
A23187 restores microneme secretion. However, treatment with KH7+DiB does not restore microneme secretion.
doi:10.1371/journal.ppat.1004520.g001
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with the Epac agonist, 8-pCPT-2’-O-Me-cAMP [34], leads to a
rise in cytosolic Ca2+ levels (Fig. 4D). This increase in Ca2+ is
blocked if merozoites are treated with ESI-09, which inhibits both
mammalian Epac 1 and Epac 2 [35] (Fig. 4D). ESI-05, which only
inhibits mammalian Epac 2 [36], does not block increase in
cytosolic Ca2+ following treatment with the Epac agonist (Fig. 4D).
In mammalian cells, Epac activated by cAMP catalyzes the
transfer of GTP to Rap1 [17]. Rap1-GTP activates PLC and
triggers a rise in cytosolic Ca2+ through the PLC pathway [17].
Stimulation of merozoites with the Epac agonist in presence of
GGTI298 [37,38], which disrupts Rap1 activity, or the PLC
inhibitor, U73122 [5,39], inhibits rise in cytosolic Ca2+ (Fig. 4E).
Fig. 2. Production of cAMP by HCO3
2 sensitive PfACb and regulation of microneme secretion. A) HCO23 sensitive adenylyl cyclase
activity in P. falciparum merozoite lysates. P. falciparum merozoite lysates were incubated with increasing concentrations of NaHCO3 (10 mM, 20 mM
and 40 mM) and ATP for 30 min at 30uC and production of cAMP was measured. Levels of cAMP are reported (mean + SD from three independent
experiments) as femtomoles per mg of merozoite protein. Merozoite lysates without exogenous ATP were used as negative controls. Production of
cAMP increased with increasing concentrations of NaHCO3. Addition of KH7 in presence of 40 mM NaHCO3 inhibited cAMP production. B)
Intracellular pH (pHi) of P. falciparum merozoites in different ionic environments with and without treatment with carbonic anhydrase (CA) inhibitor
acetazolamide (ACTZ). P. falciparum merozoites loaded with the pH-sensitive fluorescent dye BCECF-AM (inset) were transferred from IC to EC buffer
with or without prior treatment with ACTZ. Fluorescence signal from BCECF was measured and used to determine pHi using a standard curve (S6
Figure) as described in Materials and Methods. The pHi of P. falciparum merozoites remains unchanged following transfer from IC to EC buffer. Pre-
treatment of P. falciparum merozoites with ACTZ results in a rise in pHi following transfer from IC to EC buffer (EC+ACTZ). C) ACTZ blocks rise in
intracellular cAMP following transfer of P. falciparum merozoites from IC to EC buffer. P. falciparum merozoites were transferred from IC to EC buffer
with or without treatment with ACTZ. Fold change (mean 6 SD) in cAMP levels is reported from 3 independent experiments. Pre-treatment with
ACTZ inhibits rise in cAMP in merozoites following transfer from IC to EC buffer. D) ACTZ blocks microneme secretion following transfer of P.
falciparum merozoites from IC to EC buffer. P. falciparum merozoites were transferred form IC to EC buffer with or without prior treatment with CA
inhibitor, ACTZ. Secretion of PfAMA1 in merozoite supernatants (AMA1(s)) was detected by Western blotting. Presence of cytoplasmic protein PfNapL
was detected in P. falciparum merozoite supernatants (NapL(s)) and lysates of merozoite pellets (NapL(p)) under different conditions by Western
blotting to control for merozoite lysis and number of merozoites used in the different conditions, respectively. Treatment of merozoites with ACTZ
prior to transfer from IC to EC buffer inhibits secretion of microneme protein PfAMA1. Treatment of merozoites with ACTZ+IBMX, ACTZ+DiB+Epac
Agonist and ACTZ+DiB+A23187 restores microneme secretion. However, treatment with ACTZ+DiB does not restore microneme secretion.
doi:10.1371/journal.ppat.1004520.g002
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Moreover, treatment of merozoites with either ESI-09 or
GGTI298 prior to transfer from IC to EC buffer also blocks rise
in cytosolic Ca2+ (Fig. 4F) and inhibits PfAMA1 secretion (Fig. 5A,
5B). In contrast, ESI-05, which does not inhibit increase in
cytosolic Ca2+ levels (Fig. 4F), does not block secretion of PfAMA1
(Fig. 5A). Treatment of merozoites with GGT1298 together with
the Ca2+ ionophore A23187 restores microneme secretion
(Fig. 5B). Thus, a cAMP-responsive Epac-Rap1 pathway is likely
to be involved in regulating Ca2+ levels in P. falciparum
merozoites.
To confirm the role of cAMP-responsive effectors PfPKA and
PfEpac in microneme secretion, we treated merozoites in IC buffer
with the Epac agonist, the Ca2+ ionophore A23187 and DiB,
either individually or in combination. Treatment of merozoites in
IC buffer with Epac agonist, A23187 or DiB individually does not
trigger PfAMA1 secretion (Fig. 5C). However, treatment of
merozoites in IC buffer with A23187 and DiB, or Epac-agonist
and DiB triggers PfAMA1 secretion (Fig. 5C). The PLC inhibitor
U73122 blocks PfAMA1 secretion induced by treatment of
merozoites in IC buffer with Epac-agonist and DiB (Fig. 5D).
However, the inactive analog, U73343 has no inhibitory effect.
These observations suggest that Epac-agonist triggers rise in Ca2+
through the PLC pathway. Moreover, both Ca2+ and cAMP
surges are required to trigger the secretion of microneme proteins
in free merozoites.
Blockade of cAMP- & Ca2+-signaling and inhibition of
erythrocyte invasion by P. falciparum merozoites
Erythrocyte invasion assays were performed with purified
extracellular merozoites in the presence of inhibitors of cAMP-
and Ca2+-mediated signaling pathways. Merozoites were treated
with ACb inhibitor KH7, the CA inhibitor ACTZ, or Epac
inhibitors ESI-09 and ESI-05, and allowed to invade human
erythrocytes. Successful invasion events were scored by flow
cytometry using DNA intercalating dye ethidium bromide to
identify infected erythrocytes. KH7, ACTZ and ESI-09 inhibit
invasion (Fig. 5E) adding to the evidence that both cAMP and
Ca2+-dependent signaling pathways play critical roles in the
process of red cell invasion by P. falciparum merozoites.
Discussion
We have previously demonstrated that exposure of merozoites
to a low K+ environment, as found in blood plasma, triggers a rise
in cytosolic Ca2+ through a PLC mediated pathway leading to
microneme secretion [5]. Although it is clear that a rise in cytosolic
Ca2+ plays a key role in regulating microneme release, the signal
transduction mechanisms by which exposure of extra-erythrocytic
merozoites to a low K+ environment leads to a rise in cytosolic
Ca2+ were not known.
Here, we demonstrate the role of cAMP in regulating levels of
cytosolic Ca2+ and microneme secretion in response to exposure of
merozoites to a low K+ environment. The transmembrane channel
linked expressed in Paramecium, which contains a putative K+
channel-like transmembrane domain fused to the adenylyl cyclase
catalytic domain, produces cAMP when the organism is exposed
to a low K+ environment [18]. A homolog of tmAC, referred to as
ACa is expressed in blood stage Plasmodium parasites. However,
deletion of the gene encoding P. berghei ACa does not have any
deleterious effect on growth of blood stage parasites [20]. In
contrast, deletion of the gene encoding P. berghei ACa impairs
hepatocyte invasion by P. berghei sporozoites [20]. These
observations suggest that the soluble adenylyl cyclase, ACb may
play a more significant role in regulation of cAMP levels in
Plasmodium merozoites.
Here, we have used a series of pharmacological inhibitors to
explore the role of PfACb as well as other players involved in
signaling pathways that control microneme secretion. Based on the
observations made here, we propose the following model for the
regulation of microneme secretion in response to environmental
signals (Fig. 6). We propose that when merozoites are exposed to a
low K+ environment, PfCA produces HCO3
2 and H+ ions to
maintain pHi homeostasis (Fig. 6). Given the lack of information
about the nature of ion channels present on the surface of P.
falciparum merozoites, it is difficult to develop a molecular model
to explain the activation of PfCA for maintenance of pHi leading
to production of HCO3
2 when merozoites are exposed to a low
K+ environment. Production of HCO3
2 by PfCA activates PfACb
leading to a surge in cAMP levels in free merozoites (Fig. 6).
Treatment of merozoites with CA inhibitor, ACTZ, or PfACb
inhibitor, KH7, blocks production of cAMP and inhibits
microneme secretion. cAMP thus serves as a key second messenger
that regulates microneme secretion in free merozoites during red
cell invasion (Fig. 6).
Next, we demonstrated that production of cAMP in merozoites
leads to activation of the cAMP-responsive kinase, PfPKA. We
confirmed using a genetic approach that PfPKA plays a role in
microneme secretion. Over-expression of the regulatory subunit,
PfPKAr, inhibits PfPKA activity and blocks microneme secretion
implicating PfPKA in regulation of microneme secretion. PfPKA
has been shown to phosphorylate the cytoplasmic domain of
PfAMA1 during invasion [40], although the precise functional role
in the invasion process is not yet known. A global study of changes
in protein phosphorylation in merozoites following their transfer to
a low K+ environment is needed to identify the signaling pathways
involved in microneme secretion. Determination of changes in
protein phosphorylation in the presence and absence of PfPKA
inhibition will identify substrates of PfPKA that may be involved in
microneme secretion and invasion.
Given the essential roles that both Ca2+ and cAMP play in
regulating microneme secretion in free merozoites, we examined
the crosstalk between these key second messengers. Inhibiting rise
in cytosolic Ca2+ by treatment of merozoites with BAPTA-AM or
PLC inhibitor U73122 does not affect rise in cAMP when
merozoites are exposed to a low K+ environment. In contrast,
blocking a rise in cAMP with KH7 does inhibit increase in
cytosolic Ca2+ levels. Thus, a rise in cAMP levels precedes and is
necessary for an increase in cytosolic Ca2+ when merozoites are
exposed to a low K+ environment.
We explored the mechanism by which cAMP regulates cytosolic
Ca2+ levels in merozoites and found that PfEpac, rather than
PfPKA, is responsible. We present pharmacological evidence to
indicate that merozoites possess functional homologs of Epac and
Rap1 that activate PLC to trigger a rise in cytosolic Ca2+ in
response to increase in cAMP levels. A potential PfEpac is encoded
by PF3D7_1417400 (www.plasmodb.org). A search for Rap1
homologs identifies a number of P. falciparum genes predicted to
encode small GTPases. It remains to be seen which one these is
the functional homolog of Rap1 that activates PLC in response to
rise in cAMP in P. falciparum merozoites.
Previous studies with mature schizonts demonstrated that
activation of a cGMP-dependent protein kinase, PfPKG, triggers
release of proteins from micronemes and exonemes in merozoites
leading to egress [41]. Secretion of exoneme proteins such as the
protease PfSUB1 plays a critical role in merozoite egress from
infected erythrocytes [42,43]. The external, or internal signals that
trigger a rise in cGMP and activate PfPKG leading to egress are
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not known. A sharp rise in cytosolic Ca2+ in intra-erythrocytic
merozoites is also observed just prior to release of microneme and
exoneme proteins and parasite egress [5,43,44]. The pathways for
crosstalk between cGMP and Ca2+ in P. falciparum merozoites
during egress have not been defined and whether cGMP-
dependent PfPKG plays a role in microneme secretion in free
merozoites after egress is not known. It will be important to
understand the crosstalk between cGMP, cAMP and Ca2+ in
merozoites leading to apical organelle exocytosis both before and
after egress.
One possible mechanism for such crosstalk may be through
phosphorylation of the PfPKAr subunit by PfPKG that would
relieve inhibition of the catalytic PfPKAc subunit. PfPKAr displays
characteristics of both mammalian RI and RII subunits [12].
Mammalian RI and RII subunits have distinct inhibitor sites.
PfPKAr has a serine in the P-site typical of RII subunits and is
phosphorylated by PfPKA in vitro [12]. However, PfPKAr also
has a serine in the P+2 site typical of RI subunits. In mammalian
cells this site is phosphorylated by PKG [45]. Like the P-site, the
P+2 site in PfPKAr is also phosphorylated in vivo in P. falciparum
Fig. 3. cAMP responsive kinase activity in P. falciparum merozoites under different ionic conditions and microneme secretion. A)
Kemptide phosphorylation by P. falciparum 3D7 merozoite lysates under different ionic environments. P. falciparum 3D7 merozoites were transferred
from IC buffer to EC buffer with or without treatment with ACb inhibitor, KH7. Merozoite lysates made under different conditions were incubated
with kemptide, a protein kinase A (PKA) substrate, and c-32P-ATP. Fold change (mean 6 SD) in phosphorylation of kemptide under different ionic
conditions is reported relative to phosphorylation in IC buffer from 3 independent experiments. B) Kemptide phosphorylation by lysates of transgenic
P. falciparum PHL dhfr-PfPKAr merozoites under different ionic environments. P. falciparum PHL dhfr-PfPKAr merozoites were isolated in IC buffer and
transferred to EC buffer with or without treatment with dibutryl-cAMP (DiB). Phosphorylation of kemptide by merozoite lysates made under different
conditions was measured in presence of c-32P-ATP. Fold change in kemptide phosphorylation (mean 6 SD) by merozoite lysates under different
conditions is reported relative to that in IC buffer from 3 independent experiments. C) Microneme secretion in P. falciparum PHL dhfr-PfPKAr
merozoites. P. falciparum PHL dhfr-PfPKAr merozoites were transferred from IC to EC buffer, IC buffer+DiB, or EC buffer+DiB and secretion of PfAMA1
into merozoite supernatants (AMA1(s)) was detected by Western blotting. Presence of cytoplasmic protein PfNapL was detected in P. falciparum
merozoite supernatants (NapL(s)) and lysates of merozoite pellets (NapL(p)) under different conditions by Western blotting to control for merozoite
lysis and number of merozoites used in the different conditions, respectively. PfAMA1 was not secreted when P. falciparum PHL dhfr-PfPKAr
merozoites were transferred from IC to IC+DiB, or from IC to EC buffer. PfAMA1 was secreted when P. falciparum PHL dhfr-PfPKAr merozoites were
transferred from IC to EC+DiB.
doi:10.1371/journal.ppat.1004520.g003
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Fig. 4. Crosstalk between cAMP and Ca2+ in P. falciparum merozoites. A) Ca2+ does not regulate cytosolic cAMP levels. P. falciparum
merozoites were transferred from IC to EC buffer with or without treatment with BAPTA-AM or U73122. Levels of cytosolic cAMP were measured in
merozoite lysates before and after transfer to EC buffer. Fold changes in cAMP levels per mg of merozoite protein (mean 6 SD from 3 independent
experiments) in different conditions relative to cAMP levels in IC buffer (mean 6 SD) from 3 independent experiments are reported. Treatment of
merozoites with BAPTA-AM or U73122 does not have any effect on rise in intracellular cAMP levels following transfer from IC to EC buffer. B) Rise in
cytosolic Ca2+ is inhibited by ACb inhibitor KH7. P. falciparum merozoites were loaded with Fluo-4AM and transferred from IC to EC buffer with or
without treatment with KH7. Cytosolic Ca2+ levels in P. falciparum merozoites were measured before and after transfer by flow cytometry. Treatment
with KH7 inhibits the rise in cytosolic Ca2+ following transfer to EC buffer. C) PKA does not regulate cytosolic Ca2+. P. falciparum PHL dhfr-PfPKAr
merozoites were loaded with Fluo-4AM and transferred from IC to EC buffer or from IC to IC+DiB or from IC to EC+DiB. Cytosolic Ca2+ levels rise
normally following transfer of P. falciparum merozoites from IC to EC buffer. Cytosolic Ca2+ levels do not rise when P. falciparum PHL dhfr-PfPKAr
merozoites in IC buffer are treated with DiB indicating that PKA does not play a role in regulating Ca2+ levels in merozoites. D) Regulation of cytosolic
Ca2+ levels in P. falciparum 3D7 merozoites by Epac. P falciparummerozoites loaded with Fluo-4AM were transferred from IC to EC buffer or from IC to
IC buffer containing Epac agonist 8-Pcpt-2’-O-Me-cAMP (IC+Epac agonist), DiB (IC+DiB), or Epac agonist and Epac inhibitors (IC+Epac agonist+ESI-09
or IC+Epac agonist+ESI-05). Cytosolic Ca2+ levels rise when merozoites are transferred from IC to EC buffer, or IC buffer to IC+Epac agonist, but not
when they are transferred from IC buffer to IC+DiB. EPAC1 antagonist ESI-09 inhibits rise in Ca2+ stimulated by Epac agonist. E) Regulation of cytosolic
cAMP-Mediated Regulation of Microneme Exocytosis
PLOS Pathogens | www.plospathogens.org 8 December 2014 | Volume 10 | Issue 12 | e1004520
schizonts [46]. Moreover, PfPKG can phosphorylate PfPKAr in
vitro (Baker D. and Langsley G., unpublished data). Thus, PfPKG
phosphorylation of PfPKAr could provide a mechanism for
crosstalk between cGMP- and cAMP-mediated signaling.
A recent study describes a different mechanism for elevation of
cytosolic Ca2+ in merozoites leading to microneme release [47].
This study suggests that interaction of the rhoptry neck protein
PfRH1 with its erythrocyte receptor can trigger a surge in cytosolic
Ca2+ levels in merozoites leading to release of microneme proteins
such as EBA175 [47]. It remains to be seen if cAMP levels also rise
and play a role in regulating Ca2+ levels following receptor-
engagement by PfRH1. Moreover, the observation that PfRH1
knock-out parasites invade erythrocytes efficiently and display
normal blood stage growth [48] suggests that P. falciparum
merozoites must have alternative signaling mechanisms to trigger
microneme release. Whether other members of the PfRH family
such as PfRH2a/b can also mediate rise in cytosolic Ca2+ and
microneme release remains to be determined. Alternatively, as
described here, exposure to low K+ as found in blood plasma may
provide such an alternative mechanism to trigger rise in cytosolic
Ca2+ and microneme release.
Our study demonstrates that cAMP plays a central role in
regulating microneme secretion during invasion (Fig. 6). Our
data provides evidence to suggest that cAMP not only regulates
microneme secretion by activating PfPKA, but it also regulates
cytosolic Ca2+ levels by activation of PfEpac. Our definition of
the signal transduction pathways leading to rise in cAMP and
Ca2+ levels in response to external signals and the identification
of cAMP and Ca2+ responsive effectors provides multiple points
for therapeutic intervention. For example, inhibition of PfCA,
PfACb and PfEpac blocks microneme secretion and red blood
cell invasion by P. falciparum merozoites. Small molecule
inhibitors that specifically target these key-signaling molecules
may provide valuable leads for the development of novel anti-
malarial drugs that block blood stage growth of malaria
parasites.
Materials and Methods
In vitro parasite culture
P. falciparum 3D7 was cultured in complete RPMI (RPMI
1640 (Invitrogen, USA), 27.2 mg/L hypoxanthine (Sigma, USA),
0.5 gms/L Albumax I (Gibco, USA) and 2 gm/L sodium
bicarbonate (Sigma, USA) using O+ human erythrocytes under
mixed gas (5% O2, 5% CO2 and 90% N2) as described previously
[49]. P. falciparum PHL dhfr-PfPKAr was cultured in complete
RPMI according to the protocol described previously [11].
Generation of PfACb specific antisera
A peptide (1916–1930 aa) derived from PfACb (PlasmoDB ID
PF3D7_0802600) was synthesized, conjugated to keyhole limpet
hemocyanin (KLH) and used to immunize mice to obtain anti-
PfACb specific antibodies.
Generation of PfPKAr and PfPKAc specific antisera
The coding sequence of PfPKAr was amplified by PCR from P.
falciparum cDNA with primers containing BamHI and XhoI
restriction sites. The fragment was inserted into pCR2.1-TOPO
and verified by sequencing. After digestion by XhoI and BamHI
the insert was cloned into pGEX6P-1 (GE Healthcare) and
transformed into E. coli BL21 that were grown in 50 mL of LB
medium containing ampicillin (100 mg/mL, Euromedex). Recom-
binant protein expression was induced at 30uC for 4 h by addition
of 0.2 mM IPTG (Euromedex). Cells were collected by centrifu-
gation and lysed by sonication in lysis buffer (16PBS-1 mM salt,
1% Triton, EDTA, protease inhibitors). The lysate was centri-
fuged (15000 rpm, 4uC, 60 min) and the soluble fraction
incubated with glutathione sepharose beads (GE Healthcare) with
stirring at 4uC for 90 min. Beads were washed with buffer (16
PBS, 1% Triton, 1 mM EDTA), the GST-tagged recombinant
protein was eluted using increasing concentrations of glutathione.
Purified recombinant antigen was used to immunize two rats to
obtain anti-PfPKAr specific antibodies.
PfPKAc was cloned in the same way as PfPKAr. To increase
stability of the recombinant catalytic subunit, we co-expressed
PfPKAc-His with PfPKAr-GST in E. coli BL21. Transformed
bacteria were grown in 50 mL of LB medium containing
ampicillin (100 mg/mL, Euromedex). Recombinant protein
expression was induced at 37uC for 4 h by addition of 0.5 mM
IPTG (Euromedex). The bacterial pellet was washed once with 4
volumes of PBS and lysed using 4 volumes of Tris 20 mM at 4uC.
After sonication, the lysate was centrifuged (6000 g, 4uC, 15 min)
and the pellet resuspended in 3 volumes of inclusion body wash
solution (2 M Urea, 500 mM NaCl, 2% NP40, 20 mM Tris-HCl,
pH 8.0). The inclusion bodies were solubilised (5 mM Imidazole,
1 mM b-mercaptoethanol, 6 M Guanidine-HCl 6M, 20 mM
Tris-HCl pH 8.0) and recombinant protein purified by metal
affinity chromatography. His-tagged PfPKAc was eluted (8 M
Urea to 0 M Urea, 20 mM imidazole to 500 mM imidazole,
500 mM NaCl, 1 mM b-mercaptoethanol, 20 mM Tris-Hcl
pH 8.0) and used to immunize two rabbits to obtain anti-PfPKAc
specific antibodies.
Isolation of P. falciparum merozoites
P. falciparum blood stage cultures were synchronized with 5%
sorbitol for at least two successive cycles. Synchronized P.
falciparum cultures were used to isolate merozoites as described
previously [5,43]. Briefly, when majority of infected erythrocytes
reached mature schizont stage with prominent segmentation of
merozoites, the culture was resuspended in IC buffer (IC buffer –
140 mM KCl, 5 mM NaCl, 1 mM MgCl2, 5.6 mM glucose,
25 mM HEPES, pH 7.2) and schizonts were allowed to rupture to
release merozoites over one hour at 37uC. Unruptured scizonts
and uninfected erythrocytes were separated by centrifugation at
500 g for 5 min. The supernatant containing free merozoites was
centrifuged at 3300 g for 5 min to collect merozoites. The
merozoites were resuspended in IC buffer. The purity of merozoite
Ca2+ levels in P. falciparum 3D7 merozoites by Epac agonist, PLC inhibitor and Rap1 inhibitor. P falciparum merozoites loaded with Fluo-4AM were
transferred from IC to EC buffer, or from IC to IC buffer containing Epac agonist (IC+Epac agonist), or IC buffer containing Epac agonist and PLC
inhibitor (IC+Epac agonist+U73122), or IC buffer containing Epac agonist and Rap1 inhibitor GGTI298 (IC+Epac agonist+GGTI298). Cytosolic Ca2+
levels rise when merozoites are transferred from IC to EC buffer, or from IC to IC+Epac agonist. PLC inhibitor U73122 and Rap1 inhibitor GGTI298
inhibit rise in cytosolic Ca2+ stimulated by Epac agonist. F) Cytosolic Ca2+ levels in P. falciparum 3D7 merozoites following transfer to EC buffer in
presence of Epac and Rap1 inhibitors. P falciparum merozoites loaded with Fluo-4AM were transferred from IC to EC buffer containing Epac inhibitors
(EC+ESI-09 or EC+ESI-05), or EC buffer containing Rap1 inhibitor (EC+GGTI298). Cytosolic Ca2+ rises when merozoites are transferred from IC to EC
buffer. Presence of Epac inhibitor ESI-09 and Rap1 inhibitor GGTI298 inhibits rise in cytosolic Ca2+.
doi:10.1371/journal.ppat.1004520.g004
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Fig. 5. Role of Epac and PKA in regulation of microneme secretion and erythrocyte invasion by P. falciparummerozoites. P. falciparum
merozoites were transferred from IC to EC buffer with or without treatment with various inhibitors. Secretion of PfAMA1 into merozoite supernatants
(AMA1(s)) was detected by Western blotting. Cytoplasmic protein PfNapL was detected in P. falciparum merozoite supernatants (NapL(s)) and pellets
(NapL(p)) by Western blotting under different conditions to control for merozoite lysis and number of merozoites used, respectively. A) Epac inhibitor
ESI-09 blocks microneme secretion. Treatment of merozoites with 25 mM ESI-09 inhibits secretion of microneme protein PfAMA1 following transfer
from IC to EC buffer. B) Rap1 inhibitor GGTI298 blocks microneme secretion. Treatment of merozoites with GGTI298 inhibits secretion of PfAMA1
following transfer from IC to EC buffer. Treatment of merozoites with GGTI298 in presence of A23187 does not block PfAMA1 secretion. C) Inhibition
of microneme secretion by Epac and PKA pathway blockade. P. falciparum merozoites in IC buffer were treated with Ca2+ ionophore A23187 (IC+
A23187), Epac agonist 8-Pcpt-2’-O-Me-cAMP (IC+Epac Ag) or dibutryl-cAMP (IC+DiB), or with various combinations (IC+A23187+DiB or IC+Epac Ag+
DiB). Treatment of merozoites in IC buffer with Epac Ag and DiB (IC+Epac Ag+DiB) or A23187 and DiB (IC+A23187+DiB) triggers microneme secretion.
D) P. falciparum merozoites in IC buffer were treated with dibutryl-cAMP and Epac agonist (IC+Dib+Epac agonist) or DiB+Epac Ag+PLC inhibitor
U73122 or its inactive analog U73343. Treatment with U73122 inhibits microneme secretion induced by treatment with Dib and Epac Ag. E) Effect of
various inhibitors of cAMP and Ca2+ signaling pathways on erythrocyte invasion by P. falciparum merozoites. P. falciparum 3D7 merozoites were
isolated and allowed to invade erythrocytes in the presence of KH7 (50 mM), ACTZ (100 mM), ESI-09 (25 mM) and ESI-05 (25 mM). Newly invaded
trophozoites were stained with ethidium bromide and scored by flow cytometry. Merozoites were allowed to invade erythrocytes in the absence of
inhibitors as control. Percent invasion inhibition rates in presence of inhibitors are reported. Data represent mean (6 SD) from three independent
experiments with SD.
doi:10.1371/journal.ppat.1004520.g005
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preparations was confirmed by Giemsa staining (S5 Figure).
Viability of merozoite preparations was estimated by labeling
merozoites with dihydroethidine. Fluorescent merozoites were
scored by flow cytometry and viability of merozoite preparations
was estimated to be ,65%.
Drug treatments
P. falciparum merozoites were isolated in IC buffer and treated
for 15 mins with the following at concentrations shown: 100 mM
IBMX (3-isobutyl-1-methylxanthine, Calbiochem, USA), 50 mM
KH7 (Calbiochem, USA), 100 mM ACTZ (acetazolamide, Sigma,
USA), 20 mM DiB-cAMP (adenosine 3,5 cyclic monophosphate,
N6, O2- dibutyryl sodium salt, Calbiochem, USA), 10 mM Ca2+
ionophore A23187 (Calbiochem, USA), 50 mM BAPTA-AM
(Calbiochem, USA), 10 mM U73122 (Calbiochem, USA), 10 mM
U73343 (Calbiochem, USA), 200 mM Epac agonist (8-pCPT-2’-
O-Me-cAMP, Sigma, USA), 25 mM Epac antagonist ESI-05
(Biolog, Germany), 25 mM Epac antagonist ESI-09 (Biolog,
Germany) and 50 mM geranyl geranyl transferase inhibitor, GGTI
298, which disrupts Rap1 function. Merozoites were then
transferred to EC buffer (5 mM KCl, 140 mM NaCl, 1 mM
MgCl2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2)
followed by either measurement of cytosolic cAMP and Ca2+ levels
in merozoites or microneme secretion.
Microneme secretion assay
P. falciparum merozoites were isolated in IC buffer (140 mM
KCl, 5 mM NaCl, 1 mM MgCl2, 5.6 mM glucose, 25 mM
HEPES, pH 7.2), incubated for 15 min at 37uC with or without
various pharmacological inhibitors or agonists as described above
and transferred to EC buffer (5 mM KCl, 140 mM NaCl, 1 mM
MgCl2, 2 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2)
or IC-Klow buffer (5 mM NaCl, 5 mM KCl, 135 mM choline-Cl,
1 mM EGTA, 5.6 mM glucose, 25 mM HEPES, pH 7.2) with or
without pharmacological inhibitors or agonists for 15 min at 37uC.
Merozoites were separated by centrifugation as described above.
Merozoite supernatants and merozoite pellets were separated by
SDS-PAGE on a 12% gel under reducing conditions. Microneme
proteins, PfAMA1 and EBA175, were detected in merozoite
supernatants by Western blotting using anti-PfAMA1 and anti-
EBA175 rabbit sera, respectively. Rabbit sera against cytoplasmic
protein PfNapL were used to detect PfNapL in supernatants and
merozoite pellets to estimate cell lysis and confirm that similar
amounts of merozoites were used for each condition, respectively.
Horseradish peroxidase (HRP)-conjugated anti-rabbit IgG goat
antibodies (Sigma, USA) were used as secondary antibodies and
detected by enhanced chemi-luminescence using ECL-Prime
Western Blotting Detection reagent (GE Healthcare).
Measurement of intracellular cAMP levels
P. falciparum merozoites were lysed with 0.1 N HCl and
clarified by centrifugation at 6000 g. Supernatants were used for
measuring the cytosolic levels of cAMP using cAMP direct
immunoassay kit (Calbiochem, USA) as per manufacturer’s
protocol. The kit uses a polyclonal antibody to bind cAMP
present in the sample in a competitive manner. A standard curve
was generated using known amounts of cAMP standards provided
in the kit. Quantitative measurement of cAMP was obtained from
the equation derived from the standard curve. The total protein
content in each merozoite lysate sample was determined using
Fig. 6. Model for cAMP and Ca2+ mediated signaling pathways that regulate microneme secretion in P falciparum merozoites.
Exposure of P. falciparum merozoites to low K+ environment as present in blood plasma leads to production of H+ and HCO3
2 ions by carbonic
anhydrase (CA) to maintain pH. HCO3
2 ions activate cytoplasmic adenylyl cyclase (ACb) leading to rise in cytosolic levels of cAMP. Elevation of cAMP
activates its downstream effectors PKA and Epac. Epac activates Rap1 by transferring GTP. Rap1-GTP activates PLC leading to rise in cytosolic Ca2+
levels, which leads to activation of calcium dependent protein kinase 1 (CDPK1) and calcium dependent phosphatase, calcineurin (CN), both of which
directly play roles in microneme secretion. Mn, micronemes; Rh, rhoptries.
doi:10.1371/journal.ppat.1004520.g006
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Pierce BCA Protein Assay Kit (Pierce, USA) based on bicinch-
oninic acid (BCA). The amount of cAMP per mg of protein in each
merozoite lysate sample was determined and used to calculate fold
increase in cAMP per mg of merozoite protein material in each
sample compared to control (merozoites in IC buffer).
Adenylyl cyclase activity assay
P falciparum merozoites were isolated in RPMI 1640 as
described, washed twice with phosphate buffered saline (PBS) and
resuspended in 50 mM Tris pH 7.5, 150 mM NaCl. Merozoites
were lysed by repeated freeze-thaw cycles and the lysate was
clarified by centrifugation at 6000 g for 1 min at 4uC. The
supernatant was incubated with different concentrations of
NaHCO3 (0 mM, 10 mM, 20 mM and 40 mM) in the presence
of 10 mM MgCl2, 10 mM CaCl2, 5 mM ATP and 500 mM
IBMX for 30 min at 30uC. The soluble adenylyl cyclase inhibitor
KH7 (50 mM) was used as negative control. The reactions were
stopped by the addition of 0.1 N HCl and the level of cAMP
produced was measured using the cAMP direct immunoassay kit
as described above.
Protein kinase A activity assay
P. falciparum merozoites were isolated as described above and
incubated with or without KH7 (50 mM) in IC buffer for 15 min
prior to transfer to EC buffer. Merozoite pellets were collected by
centrifugation at 3000 g and used immediately to measure cAMP-
dependent protein kinase A (PKA) activity. Merozoites were
resuspended in ice-cold TNET buffer (50 mM Tris 7.4, 150 mM
NaCl, 1 mM EDTA, and 1% Triton, protease inhibitor cocktail
(Pierce, USA), 50 mM Na3VO4, 50 mM NaF) and lysed by
repeated freeze-thaw cycles (4 cycles). The lysates were cleared by
centrifugation at 6000 g for 15 min at 4uC. Total amount of
protein in the supernatant was determined by (bicinchoninic acid
assay (BCA) (Pierce, USA) using known amounts of bovine serum
albumin (BSA) as standard. PKA activity was measured by
quantitating incorporation of 32P in kemptide, a known peptide
substrate of PKA (L-R-R-A-S-L-G, Kemptide PKA peptide
substrate, Promega, USA) as described previously [9].
Measurement of intracellular pH in P. falciparum
merozoites
Intracellular pH (pHi) of P. falciparum merozoites was
measured using the pH-sensitive fluorescent dye BCECF (29,79-
bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein) [30,50]. P. fal-
ciparum merozoites were isolated in RPMI 1640 and loaded with
BCECF-AM (acetoxymethylester of BCECF, Invitrogen, USA) for
20 min at 37uC in IC buffer. The merozoites were washed to
remove excess dye and incubated with or without ACTZ in IC
buffer at 37uC for 10 min. Merozoites were collected by
centrifugation and resuspended in IC or EC buffer in the presence
or absence of ACTZ and transferred to a 96 well microtiter plate
(200 mL/well). Samples were excited monochromatically with
l1 = 440 nm and l2 = 492 nm in succession for 0–10 minutes and
emission was recorded at 535 nm on a fluorimeter (Perkin-Elmer
Victor, USA). A quantitative measure of the pHi is provided by the
ratio of the fluorescence measured at 535 nm following excitation
at 492 nm and 440 nm. For each experiment, a pH calibration
curve was prepared by resuspending merozoites in buffer
containing 130 mm KCl, 25 mM HEPES, 20 mM glucose
and 1 mM MgCl2 with a pH range of 6.6 to 8.0 followed by
the addition of 10 mm nigericin (Sigma). Nigericin equilibrates the
intracellular and extracellular pH. The equation derived from the
linear regression curve obtained by plotting the fluorescence ratio
at different pH values (S6 Figure) was used to calculate pHi of
merozoites in different conditions.
Measurement of cytosolic Ca2+ levels in P. falciparum
merozoites
P. falciparum merozoites were isolated as described above,
loaded with 10 mM Fluo-4-AM for 20 min at 37uC, washed,
resuspended in IC buffer and used for experiments within 5 min,
as described earlier [5,51]. Fluo-4-AM loaded P. falciparum
merozoites were treated with cAMP or Ca2+ modulating agents
and transferred from IC to EC buffer. Fluorescence signal from
Fluo-4 in merozoites under different conditions was measured by
flow cytometry using FACSCalibur (Becton Dickinson, USA) and
analyzed using CellQuest software. Briefly, Fluo-4-AM loaded
merozoites were excited at 488 nm and fluorescence signal was
detected with a 430 nm/30 nm band pass filter for periods of 2–
3 mins. Merozoites were gated on the basis of their forward scatter
and side scatter. The mean fluorescence intensity (MFI), which
reflects cytosolic Ca2+ levels in merozoites, was plotted against
time using FlowJo software.
Erythrocyte invasion assay by P. falciparum merozoites
P. falciparum merozoites isolated as described above were
either mock-treated or treated with 50 mm KH7 (Calbiochem,
USA), 100 mm ACTZ (Sigma, USA), 25 mM ESI-05 (Biolog,
Germany) or 25 mM ESI-09 (Biolog, Germany) for 15 min at
37uC, washed with IC buffer, resuspended in EC buffer and
incubated with erythrocytes in EC buffer at 37uC under mixed gas
environment for 2 h to allow invasion. EC buffer was then
replaced with complete RPMI. After 18–20 h of incubation in
complete RPMI under mixed gas environment to allow develop-
ment of ring stages, the percentage of infected erythrocytes was
scored by flow cytometry to determine invasion rates, as described
earlier [52].
Immunofluorescence microscopy
P. falciparum schizonts and merozoites were smeared on glass
slides, dried and fixed with pre-chilled methanol. Smears were
blocked with 3% BSA in 16 PBS for 2 h at room temperature
(RT) and probed with anti-PfACb mouse sera diluted 1:100,
followed by Alexa-Fluor 488 conjugated goat anti-mouse IgG
antibody diluted 1:200. For co-immuno-staining, smears were also
probed with rabbit sera (1:100 dilution) against the cytoplasmic
protein PfNAPL [20]. After washing, smears were incubated with
Alexa-Fluor 488-conjugated goat anti-mouse IgG (1:200, Molec-
ular Probes, USA) and Alexa-Fluor 594-conjugated goat anti-
rabbit IgG (1:200 dilution, Molecular Probes, USA), for 1 hr at
RT. The slides were washed, mounted with 49, 6-diamidino-2-
phenylindole dihydrochloride (DAPI, Molecular Probes, USA)
and antifade mounting media (Molecular Probes, USA) and
analyzed using a Nikon A1-R confocal microscope.
Supporting Information
S1 Figure Detection of P. falciparjum adenylyl cyclase b
(PfACb) in P. falciparum merozoite and schizont lysates
by western blotting. P falciparum merozoite and schizont
lysates were separated by SDS-PAGE and transferred to
nitrocellulose. Presence of PfACb was detected by Western
blotting using mouse sera raised against a peptide (1916–1930
aa) derived from PfACb (PlasmoDB ID PF3D7_0802600)
conjugated to keyhole limpet hemocyanin (KLH). Native PfACb
was detected at ,270 kDa in P. falciparum merozoite and
schizont lysates. Pre-immune mouse serum was used as negative
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control. Merozoite lysates were also probed for the cytoplasmic
protein, P. falciparum nucleosome assembly protein-L (PfNapL)
and P. falciparum merozoite surface protein MSP-1 (PfMSP1)
using anti-PfNapL rabbit sera and anti-PfMSP119 rabbit sera
respectively.
(TIFF)
S2 Figure Inhibition of EBA175 secretion with KH7. P.
falciparum merozoites were transferred from IC to EC buffer with
or without prior treatment with mammalian ACb inhibitor KH7.
Presence of EBA175 was detected in the merozoite supernatant by
Western blotting. Mouse antisera were used to detect cytoplasmic
protein NAPL in merozoite pellets as loading control and in
supernatants to control for cell lysis. EBA175 is secreted when
merozoites are transferred from IC to EC buffer. Secretion is
blocked by prior treatment of merozoites with KH7.
(TIFF)
S3 Figure Regulation of microneme secretion by treat-
ment of P. falciparum merozoites with increasing
concentrations of NaHCO3. P. falciparum merozoites in IC
buffer were transferred to IC buffer containing increasing
concentrations of NaHCO3 (10 mM, 20 mM and 40 mM), EC
buffer or EC buffer +40 mM NaHCO3 for 15 min at 37uC.
Secretion of PfAMA1 into merozoite supernatants (AMA1(s)) was
detected by Western blotting. Cytoplasmic protein PfNapL was
detected in P. falciparum merozoite supernatants (NapL(s)) and
pellets (NapL(p)) by Western blotting under different conditions to
control for merozoite lysis and number of merozoites used,
respectively. Treatment of merozoites with NaHCO3 triggers
secretion of microneme protein PfAMA1 in IC buffer in a
concentration dependent manner.
(TIFF)
S4 Figure Expression of PKA regulatory subunit (PKAr)
in P. falciparum schizonts. A) Detection of PKAr in schizonts
of P. falciparum lines PHL-dhfr-PKAr and P. falciparum PHL-
dhfr-luciferase by Western blotting. Lysates of P. falciparum PHL-
dhfr-luciferase and P. falciparum PHL-dhfr-PfPKAr schizonts
were separated by SDS-PAGE, transferred to nitrocellulose and
probed for presence of PfPKAr by Western blotting using rat
anti-PfPKAr serum. Antisera raised against P. falciparum aldolase
were used as loading control. The band intensity corresponding to
PKAr was higher in PHL-PfPKAr schizont lysates in comparison
to PHL-luciferase schizont lysates, whereas the reactivity of anti-
Pfaldolase serum was similar confirming equal loading. The
specificity of Western blot detection was confirmed by
incubation of anti-PfPKAr serum with excess of recombinant
PfPKAr prior to detection by Western blotting. B) Detection of
PKAr in P. falciparum 3D7 merozoites by immunofluorescence
assay (IFA). Mouse sera raised against PfPKAr and rabbit sera
raised against PfMSP119 were used in IFA to detect expression
and localize PfPKAr and PfMSP1 respectively. There is
significant overlap between PfPKAr and PfMSP indicating that
a significant portion of PfPKAr is associated with the merozoite
plasma membrane.
(TIFF)
S5 Figure Viabilty and purity of P. falciparum merozo-
ites. Viabilty of P. falciparum merozoites was analyzed by
staining with dihydroethidine (DHE). P. falciparum merozoites
were incubated with DHE (10 mg/ml) for 20 min at 37uC after
purification. A) DHE-stained merozoites were further stained with
nuclear staining dye DAPI and visualized using a confocal Nikon
A1R microscope. B) DHE-stained merozoites were also analyzed
by flow cytometry using a FACS Calibur (Becton & Dickinson,
USA). 100,000 RBCs were scored per sample for fluorescence
staining with DHT to determine percentage of merozoites that are
viable.
(TIFF)
S6 Figure Standard curve for measurement of intracel-
lular pH in P falciparum merozoites. P. falciparum
merozoites were loaded with pH sensitive fluorescent dye
BCECF-AM, resuspended in buffer at 10 different pH conditions
(6.4, 6.6, 6.8, 7.0, 7.2, 7.4, 7.6, 7.8, 8.0) and treated with nigericin
for 10 min at 37uC to allow extracellular and intracellular pH to
equilibrate. Samples were excited at 440 nm and 492 nm and
mean fluorescent intensity (MFI) was measured at 535 nm. Ratio
of MFI measured at 535 nm following excitation at 492 nm and
440 nm was plotted against pH to generate a standard curve.
(TIFF)
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